Aroa Biosurgery boosts Symphony clinical case with faster diabetic wound healing | Stockhead

ARX (ASX:ARX) has boosted the case for Symphony, with a RCT finding better healing outcomes for DFUs compared to standard care.

Continue in Briflio to read, react, comment, and share.